Total Funding
13
52
Total FundingVenture - Series Unknown raised
Growth Score 13 in past quarter
-8 pts
Heat Score 52 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
338998
MatrixBio develops metabolite-profiling technology for disease diagnosis, drug therapy analysis, and drug development.
- Daniel Raftery: Founder
About the Company
Breast cancer is the second most common cancer in American women, claiming more than 41,000 lives each year. Many women at high risk live with constant worry. Once a woman is diagnosed with breast cancer, it never leaves her side even if it is in remission. Providing an alternative to fear in the form of more accurate, reliable tests for the
detection and monitoring of breast cancer is what drives Matrix-Bio to excel in the emerging field of metabolite profiling.

